SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Christina Spence has been named executive director of the Life Care Center of Escondido, a skilled nursing and rehabilitation facility.
San Diego’s Fate Therapeutics has raised $10.3 million in an equity deal, according to a recent form filed with the Securities and Exchange Commission.
Ireland-based Zenith Technologies is opening a new site in San Diego to meet demand for its services on the West Coast.
Local startup Singlera Genomics has raised $20 million in a Series A round, the company announced Monday.
San Diego medtech giant Illumina Inc., the world’s largest developer of DNA sequencing machines, reportedly has received a $30 billion takeover offer from global firm Thermo Fisher Scientific.
PHARMA: Orexigen Readies for Contrave’s Make-or-Break Sales Push
Orexigen Therapeutics Inc. should stand among the elite in San Diego’s life science community as one of the few local companies that has an approved drug on the market — and real revenue filling its coffers.
San Diego medtech giant Illumina Inc. is said to have received a $30 billion takeover offer from global firm Thermo Fisher Scientific.
San Diego startup Avelas Biosciences has landed $20 million in a Series C round to develop its fluorescent technologies for cancer treatments.
San Diego’s MabVax Therapeutics Holdings Inc. is uplisting to the Nasdaq from the OTCQB market, as well as selling $8.6 million in a public equity offering.
Health insurer Blue Shield of California plans to shut down most of its operations during the four days after Labor Day as a way of coping with what it calls the unsustainable situation of providing coverage for subscribers at prices “well below” its costs.
San Diego’s Histogen Inc., a regenerative medicine company, has received a $6 million private equity investment from China-based Pineworld Capital Ltd. for the development of Histogen’s hair growth program.
The Epstein Family Foundation has granted Sanford Burnham Prebys Medical Discovery Institute $1 million to pursue pancreatic and prostate cancer research.
PatientSafe Solutions Inc. this month reported selling nearly $4.5 million in notes convertible to preferred stock in the San Diego-based health-care information technology company.
San Diego drugmaker Arena Pharmaceuticals Inc. announced that Vincent Aurentz is joining the company as executive vice president and chief business officer, effective today.
The former chief medical officer of pharmaceutical giant Celgene Corp., Dr. Jerome Zeldis, is joining San Diego’s Sorrento Therapeutics Inc. as its new chief medical officer and president of clinical development.